Skip to main content
Top
Published in: Lung 5/2011

01-10-2011

Comparison Between Cardiopulmonary Exercise Testing Parameters and Computed Tomography Findings in Patients with Thoracic Sarcoidosis

Authors: Agnaldo José Lopes, Sara Lucia Silveira de Menezes, Cristina Márcia Dias, Juliana Flávia de Oliveira, Míriam Raquel Meira Mainenti, Fernando Silva Guimarães

Published in: Lung | Issue 5/2011

Login to get access

Abstract

Background

Cardiopulmonary exercise testing (CPET) is a safe and clinically useful method to assess functional capacity and to follow disease progression and the response to treatment in several clinical conditions.

Aim

We set out to determine the relationship between outcome measures of CPET and high-resolution computed tomography (HRCT) findings in thoracic sarcoidosis.

Methods

A cross-sectional study was carried out in which 42 nonsmoking outpatients (22 females; median age = 46.5 years) were evaluated. All the patients underwent pulmonary function tests (PFTs) and CPET. By using CPET, the most probable causes of exercise limitation were separated into respiratory mechanics (n = 25) and cardiovascular (n = 17). By using HRCT, the following patterns were recorded: predominant nodules (n = 18), predominant ground-glass opacity (n = 10), and predominant traction bronchiectasis and honeycombing (n = 14).

Results

Although significant differences have been shown for both PFT parameters and CPET results, only the latter were able to distinguish between patients with ground-glass opacity and patients with traction bronchiectasis and honeycombing on HRCT. A statistically significant difference was found for peak VO2, breathing reserve, and P(A-a)O2 when patients with predominant traction bronchiectasis and honeycombing were compared to patients with other HRCT patterns (p < 0.0001). There was no statistical difference among the patterns with abnormal CPET and the patterns of abnormalities on HRCT (p > 0.05).

Conclusion

The functional capacity assessed by CPET was strongly influenced by HRCT patterns in sarcoidosis. Patients with traction bronchiectasis and honeycombing have lower exercise capacity measured by CPET.
Literature
1.
go back to reference [No authors listed] (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160:736–755 [No authors listed] (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160:736–755
2.
go back to reference Miller BH, Rosado-de-Christenson ML, McAdams HP, Fishback NF (1995) Thoracic sarcoidosis: radiologic-pathologic correlation. RadioGraphics 15:421–437PubMed Miller BH, Rosado-de-Christenson ML, McAdams HP, Fishback NF (1995) Thoracic sarcoidosis: radiologic-pathologic correlation. RadioGraphics 15:421–437PubMed
3.
go back to reference Criado E, Sánchez M, Ramírez J, Arguis P, Caralt TM, Perea RJ, Xaubet A (2010) Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. RadioGraphics 30:1567–1586PubMedCrossRef Criado E, Sánchez M, Ramírez J, Arguis P, Caralt TM, Perea RJ, Xaubet A (2010) Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. RadioGraphics 30:1567–1586PubMedCrossRef
4.
go back to reference Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A (1994) Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 191:675–680PubMed Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A (1994) Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 191:675–680PubMed
5.
go back to reference Muers MF, Middleton WG, Gibson GJ, Prescott RJ, Mitchell DN, Connolly CK, Harrison BD (1997) A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment. Sarcoidosis Vasc Diffuse Lung Dis 14:46–56PubMed Muers MF, Middleton WG, Gibson GJ, Prescott RJ, Mitchell DN, Connolly CK, Harrison BD (1997) A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment. Sarcoidosis Vasc Diffuse Lung Dis 14:46–56PubMed
6.
go back to reference American Thoracic Society/American College of Chest Physicians (2003) ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167:211–277CrossRef American Thoracic Society/American College of Chest Physicians (2003) ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167:211–277CrossRef
8.
go back to reference Barros WGP, Neder JA, Pereira CAC, Nery LE (2004) Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis. Respiration 71:367–373PubMedCrossRef Barros WGP, Neder JA, Pereira CAC, Nery LE (2004) Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis. Respiration 71:367–373PubMedCrossRef
9.
go back to reference Kollert F, Geck B, Suchy R, Jörres RA, Arzt M, Heidinger D, Hamer OW, Prasse A, Müller-Quernheim J, Pfeifer M, Budweiser S (2011) The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med 105:122–129PubMedCrossRef Kollert F, Geck B, Suchy R, Jörres RA, Arzt M, Heidinger D, Hamer OW, Prasse A, Müller-Quernheim J, Pfeifer M, Budweiser S (2011) The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med 105:122–129PubMedCrossRef
10.
11.
go back to reference Alhamad EH, Shaik SA, Idrees MM, Alanezi MO, Isnani AC (2010) Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis. BMC Pulm Med 10:42PubMedCrossRef Alhamad EH, Shaik SA, Idrees MM, Alanezi MO, Isnani AC (2010) Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis. BMC Pulm Med 10:42PubMedCrossRef
12.
go back to reference Terasaki H, Fujimoto K, Müller NL, Sadohara J, Uchida M, Koga T, Aizawa H, Hayabuchi N (2005) Pulmonary sarcoidosis: comparison of findings of inspiratory and expiratory high-resolution CT and pulmonary function tests between smokers and nonsmokers. AJR Am J Roentgenol 185:333–338PubMed Terasaki H, Fujimoto K, Müller NL, Sadohara J, Uchida M, Koga T, Aizawa H, Hayabuchi N (2005) Pulmonary sarcoidosis: comparison of findings of inspiratory and expiratory high-resolution CT and pulmonary function tests between smokers and nonsmokers. AJR Am J Roentgenol 185:333–338PubMed
13.
go back to reference Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force (2005) Standardization of spirometry. Eur Respir J 26:319–338PubMedCrossRef Miller MR, Hankinson J, Brusasco V, ATS/ERS Task Force (2005) Standardization of spirometry. Eur Respir J 26:319–338PubMedCrossRef
14.
go back to reference Medinger AE, Khouri S, Rohatgi PK (2001) Sarcoidosis: the value of exercise testing. Chest 120:93–101PubMedCrossRef Medinger AE, Khouri S, Rohatgi PK (2001) Sarcoidosis: the value of exercise testing. Chest 120:93–101PubMedCrossRef
15.
go back to reference Pereira CAC, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33:397–406PubMedCrossRef Pereira CAC, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33:397–406PubMedCrossRef
16.
go back to reference Neder JA, Andreoni S, Peres C, Nery LE (1999) Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res 32:729–737PubMedCrossRef Neder JA, Andreoni S, Peres C, Nery LE (1999) Reference values for lung function tests. III. Carbon monoxide diffusing capacity (transfer factor). Braz J Med Biol Res 32:729–737PubMedCrossRef
17.
go back to reference Sietsema KE, Kraft M, Ginzton L, Sharma OP (1992) Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 102:838–845PubMedCrossRef Sietsema KE, Kraft M, Ginzton L, Sharma OP (1992) Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 102:838–845PubMedCrossRef
18.
go back to reference Gibbons WJ, Levy RD, Nava S, Malcolm I, Marin JM, Tardif C, Magder S, Lisbona S, Cosio MG (1991) Subclinical cardiac dysfunction in sarcoidosis. Chest 100:44–50PubMedCrossRef Gibbons WJ, Levy RD, Nava S, Malcolm I, Marin JM, Tardif C, Magder S, Lisbona S, Cosio MG (1991) Subclinical cardiac dysfunction in sarcoidosis. Chest 100:44–50PubMedCrossRef
19.
go back to reference Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ (2005) Principles of exercise testing and interpretation: including pathophysiology and clinical applications, 4th ed. Lippincott Willians and Wilkins, Philadelphia Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ (2005) Principles of exercise testing and interpretation: including pathophysiology and clinical applications, 4th ed. Lippincott Willians and Wilkins, Philadelphia
20.
go back to reference Neder JA, Nery LE, Castelo A, Andreoni S, Lerario MC, Sachs A, Silva AC, Whipp BJ (1999) Prediction of metabolic and cardio-pulmonary responses to maximum cycle ergometry: a randomized study. Eur Respir J 4:1304–1313CrossRef Neder JA, Nery LE, Castelo A, Andreoni S, Lerario MC, Sachs A, Silva AC, Whipp BJ (1999) Prediction of metabolic and cardio-pulmonary responses to maximum cycle ergometry: a randomized study. Eur Respir J 4:1304–1313CrossRef
21.
go back to reference Leung AN, Miller RR, Müller NL (1993) Parenchymal opacification in chronic infiltrative lung disease: CT-pathologic correlation. Radiology 188:209–214PubMed Leung AN, Miller RR, Müller NL (1993) Parenchymal opacification in chronic infiltrative lung disease: CT-pathologic correlation. Radiology 188:209–214PubMed
22.
go back to reference Hansell DM, Milne DG, Wilsher ML, Wells AU (1998) Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 209:697–704PubMed Hansell DM, Milne DG, Wilsher ML, Wells AU (1998) Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 209:697–704PubMed
23.
go back to reference Lamberto C, Nunes H, Le Toumelin P, Duperron F, Valeyre D, Clerici C (2004) Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Chest 125:2061–2068PubMedCrossRef Lamberto C, Nunes H, Le Toumelin P, Duperron F, Valeyre D, Clerici C (2004) Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange. Chest 125:2061–2068PubMedCrossRef
24.
go back to reference Akira M, Kozuka T, Inoue Y, Sakatani M (2005) Long-term follow-up scan evaluation in patients with pulmonary sarcoidosis. Chest 127:185–191PubMedCrossRef Akira M, Kozuka T, Inoue Y, Sakatani M (2005) Long-term follow-up scan evaluation in patients with pulmonary sarcoidosis. Chest 127:185–191PubMedCrossRef
25.
go back to reference Harrison BDW, Shaylor JM, Stokes TC, Wilkes AR (1991) Airflow limitation in sarcoidosis—a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 85:59–64PubMedCrossRef Harrison BDW, Shaylor JM, Stokes TC, Wilkes AR (1991) Airflow limitation in sarcoidosis—a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 85:59–64PubMedCrossRef
26.
go back to reference Alhamad EH, Lynch JP III, Martinez FJ (2001) Pulmonary function tests in interstitial lung disease: what role do they have? Clin Chest Med 22:715–750PubMedCrossRef Alhamad EH, Lynch JP III, Martinez FJ (2001) Pulmonary function tests in interstitial lung disease: what role do they have? Clin Chest Med 22:715–750PubMedCrossRef
27.
go back to reference Arcasoy SM, Christie JD, Pochettino A, Rosengard BR, Blumenthal NP, Bavaria JE, Kotloff RM (2001) Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 120:873–880PubMedCrossRef Arcasoy SM, Christie JD, Pochettino A, Rosengard BR, Blumenthal NP, Bavaria JE, Kotloff RM (2001) Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 120:873–880PubMedCrossRef
28.
go back to reference Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS (1995) Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 107:323–329PubMedCrossRef Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS (1995) Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 107:323–329PubMedCrossRef
29.
go back to reference Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211PubMed Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211PubMed
Metadata
Title
Comparison Between Cardiopulmonary Exercise Testing Parameters and Computed Tomography Findings in Patients with Thoracic Sarcoidosis
Authors
Agnaldo José Lopes
Sara Lucia Silveira de Menezes
Cristina Márcia Dias
Juliana Flávia de Oliveira
Míriam Raquel Meira Mainenti
Fernando Silva Guimarães
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
Lung / Issue 5/2011
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-011-9316-1

Other articles of this Issue 5/2011

Lung 5/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.